Related Experiment Video
Updated: Mar 20, 2026

04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
21.0K
Pulmonary Alveolar Microlithiasis - Clinico-Radiological dissociation - A case report with Radiological review
Sanjay Mhalasakant Khaladkar1, Sushen Kumar Kondapavuluri1, Anubhav Kamal1
1Department of Radiodiagnosis, Dr. D. Y. Patil Medical College and Research center, Pimpri, Pune, India.
Journal of Radiology Case Reports
|May 21, 2016
Summary
Pulmonary alveolar microlithiasis (PAM) is a rare lung disease caused by calcium phosphate buildup. Genetic mutations affecting phosphate clearance are implicated in its development.
Area of Science:
- Pulmonary Medicine
- Genetics
- Radiology
Background:
- Pulmonary alveolar microlithiasis (PAM) is a rare chronic lung disease characterized by intra-alveolar calcium and phosphate deposition.
- The exact etiology is unknown, but mutations in the SLC34A2 gene, affecting sodium-phosphate co-transport in alveolar type-II cells, are implicated.
- PAM often presents asymptomatically until the development of hypoxemia and cor pulmonale.
Observation:
- A case of a 44-year-old male with progressive shortness of breath and dry cough is presented.
- Chest radiography revealed a characteristic 'sandstorm' appearance due to dense micronodular opacities.
- High-resolution computed tomography (HRCT) demonstrated microcalcifications, subpleural cystic changes, and pleural calcifications.
Findings:
- Lung biopsy confirmed the presence of calcospherites within alveolar spaces, consistent with PAM.
- The case highlights the typical radiological and pathological findings of pulmonary alveolar microlithiasis.
- The patient's symptoms and diagnostic findings align with the known progression of the disease.
Implications:
- This case report contributes to the understanding of pulmonary alveolar microlithiasis presentation and diagnosis.
- It underscores the importance of genetic factors, specifically SLC34A2 mutations, in the pathogenesis of PAM.
- Further research into the clearance mechanisms of calcium phosphate in the lungs may lead to novel therapeutic strategies.

